secwatch.observer — SEC 8-K summary
======================================

Issuer:     GT Biopharma, Inc. (GTBP)
CIK:        0000109657
Form:       8-K
Filed at:   2025-02-26T23:59:59+00:00
Accession:  0001493152-25-008387
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

GT Biopharma induces exercise of 302K warrants at $2.27, raises ~$0.7M; issues new warrants for 604K shares
--------------------------------------------------------------------------------

- Entered inducement letters with holders of 302,069 existing warrants to exercise at reduced price of $2.27/share, raising ~$0.7M gross proceeds.
- In exchange, issued Series A (5-year term) and Series B (18-month term) inducement warrants at $2.02 exercise price for up to 604,138 shares total.
- New warrants are unregistered; company to file resale registration statement within 30 days.
- Net proceeds to be used for working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/109657/000149315225008387/0001493152-25-008387-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/109657/000149315225008387/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-008387

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer